The Allstate Co. (NYSE:ALL) Shares Bought by Quest Partners LLC

Quest Partners LLC lifted its position in The Allstate Co. (NYSE:ALL) by 9.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,606 shares of the insurance provider’s stock after acquiring an additional 1,183 shares during the quarter. Quest Partners LLC’s holdings in Allstate were worth $2,580,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Northwest Investment Counselors LLC acquired a new position in shares of Allstate in the 3rd quarter worth approximately $28,000. Catalyst Capital Advisors LLC acquired a new position in shares of Allstate in the 3rd quarter worth approximately $29,000. Versant Capital Management Inc grew its position in shares of Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in shares of Allstate in the 2nd quarter worth approximately $38,000. Finally, MCF Advisors LLC grew its position in shares of Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Stock Up 0.6 %

Shares of Allstate stock opened at $196.88 on Monday. The stock’s fifty day moving average is $190.01 and its 200-day moving average is $176.80. The firm has a market capitalization of $52.13 billion, a PE ratio of 12.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.48. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 12-month low of $131.65 and a 12-month high of $201.00.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same period in the previous year, the firm earned $0.81 earnings per share. Allstate’s revenue for the quarter was up 14.7% compared to the same quarter last year. Equities analysts anticipate that The Allstate Co. will post 16.01 earnings per share for the current year.

Allstate Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.87%. Allstate’s dividend payout ratio is 23.83%.

Insider Activity

In other news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. The trade was a 50.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 57.06 % decrease in their position. The disclosure for this sale can be found here. 1.80% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently issued reports on ALL shares. Barclays boosted their price objective on Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research report on Thursday, October 31st. UBS Group boosted their price objective on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 4th. TD Cowen lifted their target price on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. Bank of America lifted their target price on Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, Wells Fargo & Company lifted their target price on Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $214.19.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.